Latest news
Iconovo looks to the US where it now meets quality requirements
Biostock published September 24th an article about Iconovo that can be found in its entirety below
One of Iconovo’s goals is to launch future inhalation…
Iconovo meets US Quality System regulation for medical devices
Iconovo AB (publ), that develops complete inhalation products for a global market today annonces that the company´s Quality Management System…
Press releases
Apr 24, 2025, 08:55
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Apr 24, 2025, 08:37
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
Apr 24, 2025, 08:37
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
Apr 24, 2025, 08:35
News
IR
English
Regulatory
MAR
Corporate Action
Other
Apr 24, 2025, 08:35
News
IR
Swedish
Regulatory
MAR
Corporate Action
Other
Mar 31, 2025, 08:30
News
IR
English
Corporate Action
Other
Mar 31, 2025, 08:30
News
IR
Swedish
Corporate Action
Other
Mar 03, 2025, 13:42
News
IR
English
Corporate Action
Other
Mar 03, 2025, 13:42
News
IR
Swedish
Corporate Action
Other
Feb 27, 2025, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Yearend
Feb 27, 2025, 08:30
News
IR
English
Regulatory
MAR
Report
Interim
Yearend
Jan 13, 2025, 08:30
News
IR
English
Corporate Action
Other
Jan 13, 2025, 08:30
News
IR
Swedish
Corporate Action
Other
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
Interim CEO
Anders Månsson
Mail: anders.mansson@iconovo.se